Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-13

Clinical Trial Update: Ketamine Treatment Effects on Synaptic Plasticity in Depression [Phase 4]

View source ↗

Summary

Phase 4 trial examining ketamine's effects on synaptic plasticity in major depressive disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2023-11-13